INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
83 hedge funds and large institutions have $136M invested in Infinity Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+28
Holders Change %
+50.91%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
25
Reduced
9
Closed
9
Calls
$1.66M
Puts
$1.78M
Net Calls
-$124K
Net Calls Change
-$117K
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$21.2M |
| 2 |
Millennium Management
New York
|
+$7.56M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$5.33M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.92M |
| 5 |
TLP
Tri Locum Partners
New York
|
+$3.91M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$29.2M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$6.72M |
| 3 |
Renaissance Technologies
New York
|
-$3.49M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$1.11M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$893K |
